Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis.

ABSTRACT:

Objective

To compare medication adherence, pulmonary exacerbations, healthcare utilization, and costs for patients with cystic fibrosis (CF) who utilized a pharmacy-based therapy management program to a matched control group. We hypothesized that patient management services would be associated with better medication adherence, and thus require fewer visits to the emergency room or hospitalizations.

Methods

This retrospective, observational cohort study used claims data from the MORE² claims Registry®. The sample consisted of CF patients, aged 6+, who had ≥1 pharmacy claim for inhaled tobramycin, inhaled aztreonam, ivacaftor, or dornase alfa from 6/2/2014-5/31/2015. Adherence was measured as proportion of days covered (PDC). Propensity score matching and multivaria

SUBMITTER: Kirkham HS 

PROVIDER: S-EPMC6001460 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature